Bank of Montreal
IMGN

Bank of Montreal’s Immunogen Inc IMGN Stock Holding History

Bank of Montreal’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-120,073
Closed -$3.57M – 4485
2023
Q4 		$3.57M Sell
120,073
-3,447
-3% -$68.6K ﹤0.01% 1407
2023
Q3 		$1.95M Sell
123,520
-198,175
-62% -$3.3M ﹤0.01% 1714
2023
Q2 		$6.07M Buy
321,695
+192,766
+150% +$2.28M ﹤0.01% 1247
2023
Q1 		$500K Buy
128,929
+37,060
+40% +$158K ﹤0.01% 2458
2022
Q4 		$460K Buy
91,869
+76,110
+483% +$413K ﹤0.01% 2655
2022
Q3 		$82 Buy
15,759
+4,769
+43% +$25.1K ﹤0.01% 3514
2022
Q2 		$47 Buy
+10,990
New +$47.7K ﹤0.01% 3645
2022
Q1 		– Sell
-652,756
Closed -$4.88M – 4335
2021
Q4 		$4.88M Buy
+652,756
New +$4.06M ﹤0.01% 1235
2021
Q2 		– Sell
-6,781
Closed -$53K – 5159
2021
Q1 		$53K Sell
6,781
-22,579
-77% -$184K ﹤0.01% 3672
2020
Q4 		$202K Buy
29,360
+20,744
+241% +$121K ﹤0.01% 3204
2020
Q3 		$37K Sell
8,616
-5,805
-40% -$23.4K ﹤0.01% 3562
2020
Q2 		$69K Buy
14,421
+13,758
+2,075% +$58.5K ﹤0.01% 3266
2020
Q1 		$2K Sell
663
-18,296
-97% -$80K ﹤0.01% 3906
2019
Q4 		$97K Buy
18,959
+5,571
+42% +$18.9K ﹤0.01% 3510
2019
Q3 		$33K Buy
13,388
+572
+4% +$1.52K ﹤0.01% 3824
2019
Q2 		$27K Buy
12,816
+12,105
+1,703% +$28.6K ﹤0.01% 4021
2019
Q1 		$2K Sell
711
-1,989
-74% -$8.62K ﹤0.01% 4171
2018
Q4 		$13K Buy
2,700
+1,046
+63% +$6.35K ﹤0.01% 3814
2018
Q3 		$15K Sell
1,654
-94,422
-98% -$908K ﹤0.01% 3810
2018
Q2 		$935K Buy
96,076
+95,413
+14,391% +$1.01M ﹤0.01% 2040
2018
Q1 		$7K Sell
663
-665
-50% -$6.57K ﹤0.01% 3868
2017
Q4 		$8K Sell
1,328
-1,016
-43% -$6.27K ﹤0.01% 3855
2017
Q3 		$18K Buy
2,344
+1,016
+77% +$6.75K ﹤0.01% 3561
2017
Q2 		$10K Sell
1,328
-66
-5% -$302 ﹤0.01% 3723
2017
Q1 		$6K Buy
1,394
+66
+5% +$193 ﹤0.01% 3684
2016
Q4 		$2K Buy
1,328
+663
+100% +$1.33K ﹤0.01% 3906
2016
Q3 		$2K Sell
665
-5,000
-88% -$14.5K ﹤0.01% 3874
2016
Q2 		$17K Buy
5,665
+935
+20% +$5.86K ﹤0.01% 3444
2016
Q1 		$40K Buy
4,730
+665
+16% +$5.63K ﹤0.01% 3143
2015
Q4 		$55K Hold
4,065
– – ﹤0.01% 3010
2015
Q3 		$39K Buy
4,065
+865
+27% +$12.6K ﹤0.01% 3022
2015
Q2 		$46K Hold
3,200
– – ﹤0.01% 3029
2015
Q1 		$29K Hold
3,200
– – ﹤0.01% 3136
2014
Q4 		$20K Hold
3,200
– – ﹤0.01% 3359
2014
Q3 		$34K Sell
3,200
-2,100
-40% -$23.8K ﹤0.01% 3283
2014
Q2 		$63K Buy
5,300
+2,100
+66% +$26.4K ﹤0.01% 3100
2014
Q1 		$48K Hold
3,200
– – ﹤0.01% 3143
2013
Q4 		$47K Sell
3,200
-36
-1% -$553 ﹤0.01% 2895
2013
Q3 		$55K Buy
3,236
+36
+1% +$633 ﹤0.01% 2776
2013
Q2 		$53K Buy
+3,200
New +$51.9K ﹤0.01% 2696

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of Montreal's IMGN Position: Q1 2024 in Review

Bank of Montreal sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 120,073 shares — an estimated $3.57M sold.

Bank of Montreal first reported a position in IMGN in Q2 2013 and held it in 40 quarters. The position peaked at $6.07M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Bank of Montreal reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 120,073 Immunogen Inc shares in Q1 2024, an estimated $3.57M.
  • Bank of Montreal first reported a position in Immunogen Inc in Q2 2013 and held it in 40 quarters.
  • Bank of Montreal's Immunogen Inc position peaked at $6.07M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.